1. Home
  2. EDUC vs INTS Comparison

EDUC vs INTS Comparison

Compare EDUC & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDUC
  • INTS
  • Stock Information
  • Founded
  • EDUC 1965
  • INTS 2012
  • Country
  • EDUC United States
  • INTS United States
  • Employees
  • EDUC N/A
  • INTS N/A
  • Industry
  • EDUC Consumer Specialties
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDUC Consumer Discretionary
  • INTS Health Care
  • Exchange
  • EDUC Nasdaq
  • INTS Nasdaq
  • Market Cap
  • EDUC 10.1M
  • INTS 8.7M
  • IPO Year
  • EDUC N/A
  • INTS 2023
  • Fundamental
  • Price
  • EDUC $1.30
  • INTS $0.50
  • Analyst Decision
  • EDUC
  • INTS Strong Buy
  • Analyst Count
  • EDUC 0
  • INTS 3
  • Target Price
  • EDUC N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • EDUC 12.7K
  • INTS 396.2K
  • Earning Date
  • EDUC 07-10-2025
  • INTS 05-13-2025
  • Dividend Yield
  • EDUC N/A
  • INTS N/A
  • EPS Growth
  • EDUC N/A
  • INTS N/A
  • EPS
  • EDUC N/A
  • INTS N/A
  • Revenue
  • EDUC $36,523,200.00
  • INTS N/A
  • Revenue This Year
  • EDUC N/A
  • INTS N/A
  • Revenue Next Year
  • EDUC N/A
  • INTS N/A
  • P/E Ratio
  • EDUC N/A
  • INTS N/A
  • Revenue Growth
  • EDUC N/A
  • INTS N/A
  • 52 Week Low
  • EDUC $0.92
  • INTS $0.50
  • 52 Week High
  • EDUC $2.49
  • INTS $5.28
  • Technical
  • Relative Strength Index (RSI)
  • EDUC 53.24
  • INTS 18.57
  • Support Level
  • EDUC $1.19
  • INTS $0.46
  • Resistance Level
  • EDUC $1.62
  • INTS $0.59
  • Average True Range (ATR)
  • EDUC 0.15
  • INTS 0.05
  • MACD
  • EDUC 0.01
  • INTS 0.02
  • Stochastic Oscillator
  • EDUC 25.58
  • INTS 21.14

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: